Authors:
Grant, ER
Errico, MA
Emanuel, SL
Benjamin, D
McMillian, MK
Wadsworth, SA
Zivin, RA
Zhong, Z
Citation: Er. Grant et al., Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells, BIOCH PHARM, 62(3), 2001, pp. 283-296
Authors:
Wadsworth, SA
Cavender, DE
Beers, SA
Lalan, P
Schafer, PH
Malloy, EA
Wu, W
Fahmy, B
Olini, GC
Davis, JE
Pellegrino-Gensey, JL
Wachter, MP
Siekierka, JJ
Citation: Sa. Wadsworth et al., RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase, J PHARM EXP, 291(2), 1999, pp. 680-687
Authors:
Schafer, PH
Wang, LW
Wadsworth, SA
Davis, JE
Siekierka, JJ
Citation: Ph. Schafer et al., T cell activation signals up-regulate p38 mitogen-activated protein kinaseactivity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes, J IMMUNOL, 162(2), 1999, pp. 659-668
Authors:
Schafer, PH
Wadsworth, SA
Wang, LW
Siekierka, JJ
Citation: Ph. Schafer et al., p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4(+)CD45RO(+) T cells and Th2 effector cells, J IMMUNOL, 162(12), 1999, pp. 7110-7119